These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9192538)

  • 21. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
    J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pimozide in autistic children.
    Ernst M; Magee HJ; Gonzalez NM; Locascio JJ; Rosenberg CR; Campbell M
    Psychopharmacol Bull; 1992; 28(2):187-91. PubMed ID: 1513923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
    Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.
    Wake R; Miyaoka T; Inagaki T; Furuya M; Ieda M; Liaury K; Kishi K; Horiguchi J
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):329-36. PubMed ID: 23782127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buspirone for Comorbid Anxiety in Autism.
    Gupta M; Gupta N; Moll J; Ramar D
    Prim Care Companion CNS Disord; 2023 Mar; 25(2):. PubMed ID: 36946573
    [No Abstract]   [Full Text] [Related]  

  • 28. The Relationship Between Intolerance of Uncertainty, Sensory Sensitivities, and Anxiety in Autistic and Typically Developing Children.
    Neil L; Olsson NC; Pellicano E
    J Autism Dev Disord; 2016 Jun; 46(6):1962-1973. PubMed ID: 26864157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for severe aggression in a child with autism: "open label" evaluation of multiple medications on response frequency and intensity of behavioral intervention.
    Luiselli JK; Blew P; Keane J; Thibadeau S; Holzman T
    J Behav Ther Exp Psychiatry; 2000; 31(3-4):219-30. PubMed ID: 11494958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline.
    Dalrymple KL
    Evid Based Ment Health; 2014 May; 17(2):50-1. PubMed ID: 24711363
    [No Abstract]   [Full Text] [Related]  

  • 31. Social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline.
    Fontani V; Mannu P; Castagna A; Rinaldi S
    Patient Prefer Adherence; 2011; 5():581-6. PubMed ID: 22163157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Condon's multiple-response phenomenon in severely dysfunctional children: an attempt at replication.
    Oxman J; Webster CD; Konstantareas MM
    J Autism Child Schizophr; 1978 Dec; 8(4):395-402. PubMed ID: 730663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An 8-year-old boy with autism, 1 year later.
    Parker RA; Hartman EE
    JAMA; 2002 Jan 23-30; 287(4):504. PubMed ID: 11798373
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expert opinion: investigation of drug therapy in children with autistic symptoms].
    Yamagata T; Sugie H
    No To Hattatsu; 2013 May; 45(3):223-6. PubMed ID: 23785839
    [No Abstract]   [Full Text] [Related]  

  • 35. Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline.
    Nakamura T; Sugiyama N; Sasayama D; Hagiwara T; Washizuka S
    Case Rep Psychiatry; 2017; 2017():1319505. PubMed ID: 28912994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notes on the follow-up studies of autistic children.
    KANNER L; EISENBERG L
    Proc Annu Meet Am Psychopathol Assoc; 1954-1955; ():227-39; discussion, 285-9. PubMed ID: 13273332
    [No Abstract]   [Full Text] [Related]  

  • 37. The development of performances in autistic children in an automatically controlled environment.
    FERSTER CB; DEMYER MK
    J Chronic Dis; 1961 Apr; 13():312-45. PubMed ID: 13699188
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study.
    Habibi N; Dodangi N; Nazeri A
    Iran J Med Sci; 2015 Nov; 40(6):548-9. PubMed ID: 26538787
    [No Abstract]   [Full Text] [Related]  

  • 39. Sertraline is better at reducing anxiety than depressive symptoms.
    Mahase E
    BMJ; 2019 Sep; 366():l5655. PubMed ID: 31540907
    [No Abstract]   [Full Text] [Related]  

  • 40. Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.
    McDougle CJ; Brodkin ES; Naylor ST; Carlson DC; Cohen DJ; Price LH
    J Clin Psychopharmacol; 1998 Feb; 18(1):62-6. PubMed ID: 9472844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.